Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Karuna Therapeutics Inc.

    NASDAQ: KRTX · Real-Time Price · USD
    329.83
    0.09 (0.03%)
    At close: Mar 15, 2024, 9:00 PM

    Karuna Therapeutics Statistics

    Share Statistics

    Karuna Therapeutics has 38.2M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 38.2M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 36.27M

    Failed to Deliver (FTD) Shares

    n/a
    		 3

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -26.97 and the forward PE ratio is null. Karuna Therapeutics's PEG ratio is -0.79.

    PE Ratio

    n/a
    		 -26.97

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 17886.71

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 9.33

    P/FCF Ratio

    n/a
    		 -30.09

    PEG Ratio

    n/a
    		 -0.79
    Financial Ratio History

    Enterprise Valuation

    Karuna Therapeutics has an Enterprise Value (EV) of 11.53B.

    EV / Sales

    n/a
    		 17628.09

    EV / EBITDA

    n/a
    		 -23.38

    EV / EBIT

    n/a
    		 -29.88

    EV / FCF

    n/a
    		 -29.66

    Financial Position

    The company has a current ratio of 19.31, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 19.31

    Quick Ratio

    n/a
    		 18.82

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.03

    Debt / FCF

    n/a
    		 -0.04

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is -34.58% and Return on Invested Capital is -38.99%.

    Return on Equity

    n/a
    		 -34.58%

    Return on Assets

    n/a
    		 -32.46%

    Return on Invested Capital

    n/a
    		 -38.99%

    Revenue Per Employee

    n/a
    		 $1,929.2

    Profits Per Employee

    n/a
    		 $-1,279,292.04

    Employee Count

    n/a
    		 339

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 0.05

    Taxes

    Income Tax

    n/a
    		 670K

    Effective Tax Rate

    n/a
    		 -0.15%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is 1.15, so Karuna Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.15

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 317.67

    200-Day Moving Average

    n/a
    		 228.83

    Relative Strength Index (RSI)

    n/a
    		 75.4

    Average Volume (20 Days)

    n/a
    		 971,825

    Income Statement

    In the last 12 months, Karuna Therapeutics had revenue of 654K and earned -433.68M in profits. Earnings per share was -11.73.

    Revenue

    n/a
    		 654K

    Gross Profit

    n/a
    		 -1.05M

    Operating Income

    n/a
    		 -494.78M

    Net Income

    n/a
    		 -433.68M

    EBITDA

    n/a
    		 -493.08M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -11.73
    Full Income Statement

    Balance Sheet

    The company has 185.82M in cash and 16.69M in debt, giving a net cash position of 169.13M.

    Cash & Cash Equivalents

    n/a
    		 185.82M

    Total Debt

    n/a
    		 16.69M

    Net Cash

    n/a
    		 169.13M

    Retained Earnings

    n/a
    		 -997.89M

    Total Assets

    n/a
    		 1.34B

    Working Capital

    n/a
    		 1.25B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -385.82M and capital expenditures -2.92M, giving a free cash flow of -388.74M.

    Operating Cash Flow

    n/a
    		 -385.82M

    Capital Expenditures

    n/a
    		 -2.92M

    Free Cash Flow

    n/a
    		 -388.74M

    FCF Per Share

    n/a
    		 -10.52
    Full Cash Flow Statement

    Margins

    Gross margin is -160.09%, with operating and profit margins of -75653.98% and -66311.93%.

    Gross Margin

    n/a
    		 -160.09%

    Operating Margin

    n/a
    		 -75653.98%

    Pretax Margin

    n/a
    		 -66209.48%

    Profit Margin

    n/a
    		 -66311.93%

    EBITDA Margin

    n/a
    		 -75393.88%

    EBIT Margin

    n/a
    		 -75653.98%

    FCF Margin

    n/a
    		 -59439.76%

    Dividends & Yields

    KRTX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -3.71%

    FCF Yield

    n/a
    		 -3.32%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for KRTX.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 91.07

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist